rs115116856 - EXOC2

Magnitude 4.5 · 1 study on file

Reported associations

  • Clustering of lymphoid neoplasms by cell of origin, somatic mutation and drug usage profiles: a multi-trait genome-wide association study - Unknown journal (n.d.) · Unknown authors · PubMed 40883272

    ABSTRACT: Lymphoid neoplasms (LNs) are heterogeneous malignancies arising from lymphoid cells, displaying diverse clinical and molecular features. Although LNs are collectively frequent, individual subtypes are rare, posing challenges for genetic association studies. Indeed, genome-wide association studies (GWAS) explained only a fraction of the heritability. Shared genetic susceptibility and overlapping risk factors suggest a partially common etiology across subtypes. We employed a multi-trait GWAS strategy to improve discovery power by leveraging pleiotropy among LN subtypes. We defined LN phenoclusters based on cell of origin, somatic mutation profiles, and approved therapeutic agents. Using data from three large cohorts-the UK Biobank, Million Veteran Program, and FinnGen-we analyz


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Screening

  • MGUS baseline screening and periodic monitoring High

    Variant rs115116856 in EXOC2/IRF4 associates with 2.14-fold increased MGUS risk, a precursor to multiple myeloma.

    Serum protein electrophoresis and free light chain ratio at baseline; annual follow-up testing.